What The FDA's Dispenser Warning Letter Means For DSCSA Compliance (Podcast)

At K&L Gates, we foster an inclusive and collaborative environment across our fully integrated global platform that enables us to diligently combine the knowledge and expertise of our lawyers and policy professionals to create teams that provide exceptional client solutions. With offices worldwide, we represent leading global corporations in every major industry, capital markets participants, and ambitious middle-market and emerging growth companies. Our lawyers also serve public sector entities, educational institutions, philanthropic organizations, and individuals. We are leaders in legal issues related to industries critical to the economies of both the developed and developing worlds—including technology, manufacturing, financial services, healthcare, energy, and more.

Explore Firm Details

Following the FDA's warning letter to a medical spa over Botox products, this episode examines what the enforcement action reveals about the agency's compliance expectations under the Drug Supply Chain Security Act. The discussion explores potential signals about FDA priorities and outlines practical steps dispensers should take to mitigate risk and maintain compliance.

United States Food, Drugs, Healthcare, Life Sciences

Gabriel Scott,Natalia A. Nino, and Darrell E. White, II

Article Insights

Gabriel Scott’s articles from K&L Gates LLP are most popular:

within Food, Drugs, Healthcare and Life Sciences topic(s)
in South America
in South America
with readers working within the Business & Consumer Services and Healthcare industries

K&L Gates LLP are most popular:

within Immigration and Insurance topic(s)

In this episode, Gabe Scott, Natalia Nino, and Darrell White discuss the Drug Supply Chain Security Act following the FDA's warning letter to a medical spa over Botox products. Their conversation explores what the enforcement action reveals about the agency's compliance expectations, what it may signal about the FDA’s priorities, and the steps dispensers should be taking now to mitigate risk and stay compliant.

self

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Authors

Gabriel Scott

Natalia A. Nino

What The FDA's Dispenser Warning Letter Means For DSCSA Compliance (Podcast)

Contributor

Food, Drugs, Healthcare, Life Sciences

Contributor

United States